Gastrointestinal Health

“Diversity Equals Health”; A Diverse Gut Microbiome Could Be Driving Factor to Protect Against COVID-19

November 16, 2022

Article

Like using good nutrients to grow tomatoes in the soil, good nutrients and diverse microbes are important for our good gut health, or our gut's "garden," said a leading researcher.

IBS Management Often Requires Dietary Changes, Education, and Medication

October 07, 2022

Article

The pharmacologic options for irritable bowel syndrome are based on the adverse effect profile, cost, and predominant symptoms.

Study: Increased Diet of Fish, Fiber, Omega-3 Fatty Acids May Decrease Risk of Death in Adults with Type 2 Diabetes

September 20, 2022

Article

Adults with type 2 diabetes may benefit from eating more whole grains, fish, fiber, and omega-3 fatty acids in their diet, which could lower co-morbidities associated with death.

FDA Approves Oral Liquid Formulation to Treat Gastric Issues

September 02, 2022

Article

The FDA approved Azurity Pharmaceutical’s omeprazole and sodium bicarbonate for oral suspension to treat benign gastric ulcers and it is predicted to reach commercial markets by next year.

The Role of the Microbiome in C. difficile Infection and Its Impact on Overall Health

July 01, 2022

Article

The first step to reducing recurrent C. difficile infections is prevention.

Gastroesophageal Reflux Disease

June 13, 2022

Article

Most individuals can manage the discomfort of GERD with lifestyle changes and OTC medications.

Risankizumab Demonstrates Significant Improvements In Patients with Crohn Disease

January 11, 2021

Article

A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.

Only Gastrointestinal Symptoms Present in Nearly 20% of COVID-19 Cases

November 11, 2020

Article

Despite presenting in only 18% of cases, 16% of all COVID-19 patients only present with gastrointestinal symptoms.

New Dupilumab Study Shows Improvement in Eosinophilic Esophagitis Signs, Symptoms

November 04, 2020

Article

The FDA granted breakthrough therapy designation to dupilumab in September 2020, for the treatment of patients age 12 years and older with eosinophilic esophagitis.

Help Prevent and Treat Mild to Moderate GERD

October 16, 2020

Article

Educate patients about the appropriate and safe use of gastrointestinal products and direct them to seek further medical care when warranted.